SGP insider transaction filings
SpyGlass Pharma, Inc. — 30 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-11. Screen SGP transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-11 | 4 | Khan Bilal Arshad — Director | Purchase (P): 20,000 @ $16 · Purchase (P): 115,000 @ $16 | EDGAR |
| 2026-02-11 | 4 | Yang Rick — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 1,619,240 (derivative) · +3 more | EDGAR |
| 2026-02-11 | 4 | New Enterprise Associates 17, L.P. — 10% owner NEA Partners 17, L.P. — 10% owner NEA 17 GP, LLC — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 1,619,240 (derivative) · +3 more | EDGAR |
| 2026-02-11 | 4 | Pardo Geoffrey B — Director | Conversion (C): 1,875,013 @ $0 · Purchase (P): 312,500 @ $16 · Conversion (C): 1,875,013 (derivative) | EDGAR |
| 2026-02-11 | 4 | Chang Carmen — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2026-02-11 | 4 | Makhzoumi Mohamad — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2026-02-11 | 4 | Behbahani Ali — Director, 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2026-02-11 | 4 | Florence Anthony A. Jr. — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2026-02-11 | 4 | Walker Paul Edward — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2026-02-11 | 4/A | Nielsen Kirk G. — Director | Conversion (C): 1,690,230 (derivative) · Conversion (C): 548,067 (derivative) · Conversion (C): 548,067 (derivative) · Conversion (C): 359,255 (derivative) | EDGAR |
| 2026-02-11 | 4 | Mathers Edward T — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 1,619,240 (derivative) · +3 more | EDGAR |
| 2026-02-11 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Conversion (C): 2,524,473 · Conversion (C): 1,806,644 · Purchase (P): 3,441,966 @ $16 · Purchase (P): 248,034 @ $16 · Conversion (C): 1,150,941 (derivative) · Conversion (C): 767,294 (derivative) · +4 more | EDGAR |
| 2026-02-11 | 4 | BASKETT FOREST — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2026-02-11 | 4 | SANDELL SCOTT D — 10% owner | Conversion (C): 1,619,240 · Conversion (C): 1,370,168 · Conversion (C): 1,370,168 · Conversion (C): 737,962 · Purchase (P): 937,500 @ $16 · Conversion (C): 954,990 · +7 more | EDGAR |
| 2026-02-10 | 4 | Nielsen Kirk G. — Director | Conversion (C): 1,690,230 · Conversion (C): 548,067 · Conversion (C): 548,067 · Conversion (C): 359,255 · Purchase (P): 165,000 @ $16 · Conversion (C): 9,689,922 (derivative) · +3 more | EDGAR |
| 2026-02-10 | 4 | Vensana Capital I GP, LLC — 10% owner Vensana Capital I, L.P. — 10% owner Nielsen Kirk G. — 10% owner Klein Peter Justin — 10% owner | Conversion (C): 1,690,230 · Conversion (C): 548,067 · Conversion (C): 548,067 · Conversion (C): 359,255 · Purchase (P): 165,000 @ $16 · Conversion (C): 9,689,922 (derivative) · +3 more | EDGAR |
| 2026-02-09 | 4 | Khan Bilal Arshad — Director | Grant/award (A): 13,700 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Pujara Chetan Pratap — Chief R&D Officer | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Dennewill James Robert Jr. — Chief Operating Officer | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Mooney Patrick H. — Chief Executive Officer, Director | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Kahook Malik Y. — See remarks, Director | Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Scheiner Zachary — Director | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Pardo Geoffrey B — Director | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | O'Farrell Elizabeth G. — Director | Grant/award (A): 13,700 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Dable Habib J — Director | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Behbahani Ali — Director, 10% owner | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Dybbs Michael — Director | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Nielsen Kirk G. — Director, 10% owner | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Viret Jean-Frederic — Chief Financial Officer | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund III, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
Recent 8-K events — SpyGlass Pharma, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-02-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SGP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →